{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T22:16:29Z","timestamp":1791411389171,"version":"4.3.3"},"reference-count":0,"publisher":"American Society of Hematology","issue":"13","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2002,12,15]]},"DOI":"10.1182\/blood-2002-03-0772","type":"journal-article","created":{"date-parts":[[2002,11,26]],"date-time":"2002-11-26T18:42:38Z","timestamp":1038336158000},"page":"4325-4336","source":"Crossref","is-referenced-by-count":1295,"title":["Pretreatment cytogenetic abnormalities are predictive of induction success, cumulative incidence of relapse, and overall survival in adult patients with de novo acute myeloid leukemia: results from Cancer and Leukemia Group B (CALGB 8461)"],"prefix":"10.1182","volume":"100","author":[{"given":"J. C.","family":"Byrd","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","published-online":{"date-parts":[[2002,8,1]]},"container-title":["Blood"],"original-title":[],"deposited":{"date-parts":[[2011,8,22]],"date-time":"2011-08-22T14:27:32Z","timestamp":1314023252000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.bloodjournal.org\/cgi\/doi\/10.1182\/blood-2002-03-0772"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,8,1]]},"references-count":0,"journal-issue":{"issue":"13"},"URL":"https:\/\/doi.org\/10.1182\/blood-2002-03-0772","relation":{},"ISSN":["0006-4971","1528-0020"],"issn-type":[{"value":"0006-4971","type":"print"},{"value":"1528-0020","type":"electronic"}],"subject":[],"published":{"date-parts":[[2002,8,1]]}}}